Literature DB >> 7140135

Propranolol dosage, plasma concentration, and beta blockade.

J F Mullane, J Kaufman, D Dvornik, J Coelho.   

Abstract

One hundred sixty-nine normal men received varying propranolol dosage regimens and placebo. Dose level and frequency were compared with plasma propranolol levels and beta blockade, as assessed by reduction of exercise tachycardia. Propranolol levels above 20 ng/ml induced significant beta blockade. An average daily propranolol dose slightly in excess of 160 mg led to a minimum plasma level above 20 ng/ml. Approximately 50% of subjects achieved 20 bpm or greater decrease in exercise tachycardia with 160 mg per day. The degree of beta blockade at the daily minimum propranolol level was related to dose and not dose frequency. The relation of propranolol dose and plasma levels to beta blockade in normal subjects appears to reflect observations in large clinical trials.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7140135     DOI: 10.1038/clpt.1982.225

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  Bronchoconstriction of the asthmatic airway by inhaled and ingested propranolol.

Authors:  K M Latimer; R E Ruffin
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.

Authors:  T Tateishi; H Nakashima; T Shitou; Y Kumagai; K Ohashi; S Hosoda; A Ebihara
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Pharmacokinetic and pharmacodynamic comparison of two doses of long acting propranolol (80 and 160 mg) in healthy subjects.

Authors:  B Flouvat; I Berlin; A Cournot; D Robinet; J Duchier; H Sarmini; A Rossi
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

Review 4.  Beta-adrenoceptor blockers. An update on their role in acute myocardial infarction.

Authors:  R M Norris
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

5.  Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.

Authors:  A Wellstein; D Palm; H F Pitschner; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 6.  Pharmacokinetics of long acting propranolol. Implications for therapeutic use.

Authors:  G S Nace; A J Wood
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

7.  Haemodynamic effects of verapamil administration after large doses of fentanyl in man.

Authors:  P A Kapur; E J Norel; H Dajee; G Cohen; W Flacke
Journal:  Can Anaesth Soc J       Date:  1986-03

8.  Dynamics of beta-adrenoceptor blockade with cetamolol.

Authors:  J Coelho; K Schnelle; L Joubert; D Ventura; J Mullane
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

Review 9.  The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.

Authors:  S Nattel; G Gagne; M Pineau
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

10.  Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteers.

Authors:  R L Lalonde; R J Straka; J A Pieper; M B Bottorff; D M Mirvis
Journal:  J Pharmacokinet Biopharm       Date:  1987-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.